Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors
about
Developing Combined HIV Vaccine Strategies for a Functional CureReview: Influence of ART on HIV geneticsCD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisThe detection and management of early HIV infection: a clinical and public health emergency.French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.A lower viral set point but little immunological impact after early treatment during primary HIV infectionSIV-infection-driven changes of pattern recognition receptor expression in mesenteric lymph nodes and gut microbiota dysbiosis.Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T CellsStakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like PropertiesAltered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification.Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.Modulation of Regulatory T-Cell Subsets in Very Long-Term Treated Aviremic HIV(+) Patients and Untreated Viremic Patients.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.Kill: boosting HIV-specific immune responses.HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control.[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].Multifarious immunotherapeutic approaches to cure HIV-1 infectionA heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.Modulation of polyfunctional HIV-specific CD8 T cells in patients responding differently to antiretroviral therapy.
P2860
Q26998898-7B5605B8-ECDD-44EC-AFE6-1E3CB349D0ADQ28649848-FB2EB4D4-74A3-4166-BC02-BC4EECD80CCEQ30432007-7787FA06-112F-4E1F-8BF8-6DB37E720E84Q33586581-356AA86C-8468-497F-867B-AC93A24C96F1Q33775397-4558F59F-3A19-48A4-B6A1-94F717F9BFBFQ34490157-F6A616FA-4980-4B66-8577-0FE163A7D37EQ34819446-4D7E7F1A-AA55-4DB1-8B60-F727875FC41CQ35323147-A26DE938-7BE0-4E86-8C8E-7AC28F810B9BQ35746522-5C3B4FE5-7928-4DDB-8AF2-623F5B39A277Q35795271-BFBEAA6C-15DC-430F-B3B6-093F5D35B44CQ35857623-C104C83A-09E9-471E-B66E-D11EF5EF911EQ35861157-03BC1367-7A45-438C-B1A0-6CDC320F6483Q36087130-92CC52A9-1A1A-4663-AE59-A06687A6A404Q36311695-B5D2470E-FDE0-472D-93E9-B18C41295DACQ36509593-AA1C26EC-70E3-40BC-B3E0-A7A76E135FC1Q38067705-0B65FF8C-B17C-4C1A-9B80-4A8613422F32Q38086432-C0A5EAFD-B828-422F-9BC5-132EC9F7E621Q38263002-4BED8911-4FEA-4BCF-9EE4-A5B124F0AC3BQ38433251-B75AAEA3-F5B7-4C01-8ECF-95A1AE2C2B0BQ38433342-9DEB49DF-065F-4B78-B37C-53A84C788B4CQ38800533-761BC887-319C-4A0F-BEE4-EE582DCA61C0Q40479645-C986B528-6421-4C82-A398-20E522F938A0Q40869409-F1188F26-CF47-45DE-9206-EFEFD83A5B6EQ41181556-6011CA36-AC2D-41D4-8FF6-F06C2875C149Q42562453-F5000312-727D-45A9-A3FD-D07DB48C2E12Q45930474-6BD24A43-2BD3-43A5-A158-A475D723515FQ47580241-186937C8-5864-47B0-83FA-856F3EF53549Q51839003-3134CB2E-C191-4100-AB5B-5BE3DD0BB501
P2860
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Early and prolonged antiretrov ...... t of long-term non-progressors
@ast
Early and prolonged antiretrov ...... t of long-term non-progressors
@en
type
label
Early and prolonged antiretrov ...... t of long-term non-progressors
@ast
Early and prolonged antiretrov ...... t of long-term non-progressors
@en
prefLabel
Early and prolonged antiretrov ...... t of long-term non-progressors
@ast
Early and prolonged antiretrov ...... t of long-term non-progressors
@en
P2093
P2860
P1433
P1476
Early and prolonged antiretrov ...... t of long-term non-progressors
@en
P2093
Alexandre Harari
Andrew Freedman
Anna-Maria Geretti
Anne Carroll
Cristina Cellerai
Hans Stauss
Ian Williams
John Sweeney
Jonathan Ainsworth
Margaret Johnson
P2860
P304
P356
10.1371/JOURNAL.PONE.0018164
P407
P577
2011-04-05T00:00:00Z